Measles travel advisories, New Canadian Pharmacare not covering the cost of Ozempic for people with type 2 diabetes, and a possible new treatment pathway for people suffering from Crohn’s disease. February 26, 2024February 27, 2024Dr. Barry Dworkin Medical Mythbusting Commentary for February 26, 2024 Source:Treating newly-diagnosed Crohn’s patients with advanced therapy leads to dramatic improvements in outcomes Related posts: Measles now endemic in Europe: The predictable outcome of ignorance, fake data, and anti-science Measles cases continue to increase in US hitting 25-year high Follow the bouncing ball: Measles and polio outbreaks playing hopscotch due to low vaccination rates Reaping the rewards of fake science anti-vaxxers; Measles outbreaks in Europe and Mumps in Canada Crohn'smeaslesozempicpharmacare